The Promise and Potential of Breast Cancer Vaccines with Dr. Karen Anderson

One key goal in developing precision vaccines and immune therapies is to reduce the risk of breast cancer recurrence. Yet currently, there is only one FDA-approved immunotherapy drug for breast cancer, and it benefits just a small subset of women.

In this episode of Investigating Breast Cancer, we talk with Dr. Karen Anderson about vaccines, harnessing the power of a person’s immune system, and reducing the risk of breast cancer recurrence. And of course, we’d all like to know: What’s the progress? And how has COVID-19 impacted this research?